BioSpace News Archive

Nalu Medical, Inc. (“Nalu”) announces the first patient enrollment in the Clinical Study Of A Micro-Implantable Pulse Generator For the Treatment of Peripheral Neuropathic Pain (COMFORT-2) Peripheral Nerve Stimulation Randomized Controlled Trial.

Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), and Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement to implement RightSourceSM at Wheeler Bio’s current good manufacturing practice (cGMP) biologics manufacturing facility in Oklahoma City, OK.

Triumvira Immunologics today announced that positive data from its Phase I/II trial investigating the safety and efficacy of autologous TAC01-HER2 in refractory solid tumors (TACTIC-2/NCT04727151), will be presented at the 2023 American Society Of Clinical Oncology (ASCO) Annual Meeting.

According to our new research study on “Viral Antigens Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Component, Technique, and, End User” the market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11% during 2020–2027.

According to our new research study on “GMP Cytokines Market to 2027 – Global Analysis and Forecast – by Type, Application, and Geography,” the GMP Cytokines Market Size is projected to grow from US$ 84.72 million in 2019 to US$ 158.13 million by 2027; it is expected to grow at a CAGR of 8.1% during 2020–2027.

According to our new research study on “Leukapheresis Market to 2028 – Global Analysis and Forecast – by Product Type, Application, End User, and Geography,” the Leukapheresis Market is projected to reach 133.90 million in 2028 from US$ 74.48 million in 2021

Omega Laboratories, a leading provider of laboratory testing solutions, is proud to announce that its toxicology laboratory in Ontario, Canada, has been awarded ISO 17025 accreditation.

Sun Genomics, a leader in gut health testing specializing in made-to-order probiotics based on an individual’s gut microflora, has launched the world’s first fully customizable multivitamin, Floré Multi-V.

Nephron Pharmaceuticals Corporation announced that preservative-free 0.5% Albuterol Sulfate Inhalation Solution is available now in a 25 mg/5 mL pre-filled vial.

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 44th Annual Goldman Sachs Healthcare Conference in Dana Point, CA.